Given the roles of periostin and tenascin C in promoting the expression of MMPs in CRSwNPs, our results indicate that anti‐periostin or anti‐tenascin C treatment might be able to inhibit tissue remodeling within nasal polyps, which still needs to be further verified by in vivo animal studies. The gene discussed is TNC; the disease is nasal cavity polyp.